About Mitochondrial adenyl nucleotide antiporter SLC25A23
Mitochondrial adenyl nucleotide antiporter SLC25A23 (SLC25A23) is a protein
from Homo sapiens identified by UniProt accession
Q9BV35, 468 residues long.
MolForge cross-references it against 0 known binders and
26 disease associations.
Target properties
| Protein name | Mitochondrial adenyl nucleotide antiporter SLC25A23 |
| UniProt accession | Q9BV35 |
| Gene | SLC25A23 |
| Organism | Homo sapiens |
| Length | 468 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (26)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.28
- monocyte count · score 0.11
- pentosuria · score 0.05
- FRAXF syndrome · score 0.03
- primary hyperoxaluria type 3 · score 0.03
- medulloblastoma · score 0.02
- colorectal cancer · score 0.01
- large cell medulloblastoma · score 0.01
- oral squamous cell carcinoma · score 0.01
- ulcerative colitis · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BV35-F1 | alphafold | PREDICTED | 78.38 | — |
Amino-acid sequence (468 residues)
MRGSPGDAER RQRWGRLFEE LDSNKDGRVD VHELRQGLAR LGGGNPDPGA QQGISSEGDA DPDGGLDLEE FSRYLQEREQ RLLLMFHSLD RNQDGHIDVS EIQQSFRALG ISISLEQAEK ILHSMDRDGT MTIDWQEWRD HFLLHSLENV EDVLYFWKHS TVLDIGECLT VPDEFSKQEK LTGMWWKQLV AGAVAGAVSR TGTAPLDRLK VFMQVHASKT NRLNILGGLR SMVLEGGIRS LWRGNGINVL KIAPESAIKF MAYEQIKRAI LGQQETLHVQ ERFVAGSLAG ATAQTIIYPM EVLKTRLTLR RTGQYKGLLD CARRILEREG PRAFYRGYLP NVLGIIPYAG IDLAVYETLK NWWLQQYSHD SADPGILVLL ACGTISSTCG QIASYPLALV RTRMQAQASI EGGPQLSMLG LLRHILSQEG MRGLYRGIAP NFMKVIPAVS ISYVVYENMK QALGVTSR
Explore Mitochondrial adenyl nucleotide antiporter SLC25A23 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets